Increased α-synuclein expression and its accumulation in the aging brain have been implicated in cognitive and motor dysfunction, particularly in Parkinson’s disease (Xuan et al., 2011; Yang et al., 2020). This evidence concerns the gene SNCA and Parkinson disease.